A primate model for the study of human fever

No prior work had fully established the suitability of rhesus monkeys for modeling human febrile responses. That uncertainty drove researchers to investigate how these primates react to specific pyrogenic agents. Prior research has shown that rabbits are often used for such testing, yet their physiological differences from humans remain a concern. This gap motivated the current assessment of primate responses to human-derived substances. It was already known that temperature regulation varies significantly between day and night cycles in many species. Scientists needed a reliable animal system to better understand the complex pathways involved in human fever development. The lack of standardized primate models hindered progress in evaluating potential anti-pyretic interventions. This study addresses these limitations by characterizing the febrile patterns induced by human leukocytic pyrogen in a controlled setting.

The aim of this study is to evaluate the rhesus monkey as a suitable model for investigating human fever pathophysiology. Researchers sought to determine if these primates respond to human leukocytic pyrogen in a predictable and clinically relevant manner. The study addresses the need for a non-human primate system that accurately reflects human thermal regulation. By testing the sensitivity of these animals to human-derived pyrogens, the team hoped to validate their utility for future pharmacological research. The investigation explores how different pharmacological agents influence the febrile response in this specific model. The authors also intended to characterize the impact of diurnal cycles on the magnitude of fever. This work was motivated by the limitations of existing rabbit models in capturing the full spectrum of human physiological responses. Ultimately, the researchers aimed to provide a foundation for using this primate to better understand the mechanisms underlying human fever.

The review approach involved monitoring awake, chair-restrained rhesus monkeys during controlled experimental sessions. Investigators administered semipurified human-derived pyrogens intravenously to induce measurable thermal changes. The team tracked temperature fluctuations continuously to determine the latency and duration of the febrile response. Researchers compared the efficacy of indomethacin against sodium salicylate in modulating these temperature spikes. The protocol included rapid, repeated injections to assess how cumulative exposure alters the intensity of the fever. Data collection focused on comparing responses during distinct diurnal periods to account for baseline temperature shifts. The study design ensured that each animal served as its own control to minimize variability. This systematic evaluation provided a clear framework for assessing the sensitivity of the primate system to human-specific pyrogens.

The strongest finding indicates that human leukocytic pyrogen elicits a monophasic fever in rhesus monkeys with variable onset latency. The febrile response is significantly greater at night, reaching higher peaks when baseline temperatures are lower. Intravenous indomethacin successfully reduces the fever, whereas large doses of sodium salicylate fail to produce a similar inhibitory effect. Rapid, repeated injections extend the duration of the febrile state from 1.5 to 5.5 hours. Following this extension, the subjects experience a sudden 300% to 400% increase in fever increment within a 30-minute interval. The data confirm that the rhesus monkey maintains high sensitivity to human-derived pyrogenic substances. These results establish a clear pattern of thermal regulation that mirrors human physiological responses. The findings provide quantitative evidence that this primate model effectively mimics the febrile dynamics observed in clinical settings.

The authors propose that the rhesus monkey serves as a valuable model for examining human fever pathophysiology. Their findings demonstrate that these animals exhibit sensitivity to human-derived pyrogens comparable to that observed in rabbits. The researchers suggest that the observed diurnal variations in febrile response are significant for future experimental designs. They note that indomethacin effectively modulates the fever induced by these pyrogens, unlike sodium salicylate. The study highlights that repeated exposure to pyrogens leads to a marked increase in fever duration and intensity. These results indicate that the timing of pyrogen administration influences the magnitude of the thermal response. The authors conclude that this primate model provides a robust platform for investigating the underlying mechanisms of human temperature regulation. This work supports the use of non-human primates to bridge the gap between basic laboratory findings and human clinical applications.